S&P 500   3,853.07
DOW   31,176.01
QQQ   326.36
Trump returns to a business empire ravaged by pandemic
pixel
Biden's climate steps could have big impact on energy firms
Asian stocks sink after China coronavirus resurgence
Biden Cabinet: Buttigieg urges big funds for Transportation
Global stocks sink after China coronavirus resurgence
3D Printing Stocks Offering Another Dimension of Gains
FDA approves 1st long-acting HIV drug combo, monthly shots
S&P 500   3,853.07
DOW   31,176.01
QQQ   326.36
Trump returns to a business empire ravaged by pandemic
pixel
Biden's climate steps could have big impact on energy firms
Asian stocks sink after China coronavirus resurgence
Biden Cabinet: Buttigieg urges big funds for Transportation
Global stocks sink after China coronavirus resurgence
3D Printing Stocks Offering Another Dimension of Gains
FDA approves 1st long-acting HIV drug combo, monthly shots
S&P 500   3,853.07
DOW   31,176.01
QQQ   326.36
Trump returns to a business empire ravaged by pandemic
pixel
Biden's climate steps could have big impact on energy firms
Asian stocks sink after China coronavirus resurgence
Biden Cabinet: Buttigieg urges big funds for Transportation
Global stocks sink after China coronavirus resurgence
3D Printing Stocks Offering Another Dimension of Gains
FDA approves 1st long-acting HIV drug combo, monthly shots
S&P 500   3,853.07
DOW   31,176.01
QQQ   326.36
Trump returns to a business empire ravaged by pandemic
pixel
Biden's climate steps could have big impact on energy firms
Asian stocks sink after China coronavirus resurgence
Biden Cabinet: Buttigieg urges big funds for Transportation
Global stocks sink after China coronavirus resurgence
3D Printing Stocks Offering Another Dimension of Gains
FDA approves 1st long-acting HIV drug combo, monthly shots
Log in
OTCMKTS:MTACU

MedTech Acquisition Stock Forecast, Price & News

$10.59
+0.02 (+0.19 %)
(As of 01/21/2021 12:00 AM ET)
Add
Compare
Today's Range
$10.56
Now: $10.59▼
$10.71
50-Day Range N/A
52-Week Range
$10.28
Now: $10.59▼
$11.46
Volume36,194 shs
Average Volume154,430 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
There is no company description available for Medtech Acquisition Corp.

MarketRank™

Overall MarketRank™

0.00 out of 5 stars

-- Sector

62nd out of 134 stocks

-- Industry

62nd out of 135 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry --
Sub-IndustryN/A
Sector--
Current SymbolOTCMKTS:MTACU
Previous Symbol
CUSIPN/A
CIKN/A
WebN/A
PhoneN/A
EmployeesN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable
$10.59
+0.02 (+0.19 %)
(As of 01/21/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MTACU News and Ratings via Email

Sign-up to receive the latest news and ratings for MTACU and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











MedTech Acquisition (OTCMKTS:MTACU) Frequently Asked Questions

What stocks does MarketBeat like better than MedTech Acquisition?

Wall Street analysts have given MedTech Acquisition a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but MedTech Acquisition wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of MedTech Acquisition's key competitors?

Some companies that are related to MedTech Acquisition include (GRSVU) (GRSVU), (SVOKU) (SVOKU), (TBA) (TBA), 378 (SCCB), ACE Convergence Acquisition (ACEVU), ACKRELL SPAC Partners I (ACKIU), Adit EdTech Acquisition (ADEXU), AEA-Bridges Impact (IMPXU), Aequi Acquisition (ARBGU), AllianzGI Artificial Intelligence Opportunities Fund (AIO), Altimeter Growth (AGCUU), ArcLight Clean Transition (ACTCU), Athlon Acquisition (SWETU), Atlas Crest Investment (ACICU) and Authentic Equity Acquisition (AEACU).
View all of MTACU's competitors.

What is MedTech Acquisition's stock symbol?

MedTech Acquisition trades on the OTCMKTS under the ticker symbol "MTACU."

When does MedTech Acquisition's quiet period expire?

MedTech Acquisition's quiet period expires on Wednesday, January 27th. MedTech Acquisition had issued 22,000,000 shares in its IPO on December 18th. The total size of the offering was $220,000,000 based on an initial share price of $10.00. During MedTech Acquisition's quiet period, insiders and any underwriters that worked on the IPO are restricted from issuing any research reports for the company because of SEC regulations. Following the end of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

How do I buy shares of MedTech Acquisition?

Shares of MTACU can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is MedTech Acquisition's stock price today?

One share of MTACU stock can currently be purchased for approximately $10.59.

This page was last updated on 1/22/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.